Return to content in this issue


Changes in Thymus and Activation-Regulated Chemokine in Patients With Type 2 Inflammatory Disease Receiving Dupilumab

Zhou B, Liang S, Shang S, Xiang L, Li L

Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China

J Investig Allergol Clin Immunol 2023; Vol 33(1) : 74-75
doi: 10.18176/jiaci.0874

Key words: Thymus and activation-regulated chemokine, Type 2 inflammatory disease, Atopic dermatitis, Dupilumab